Sign In
Buy ABT
$93.24
+2.73 (+3.02%)
At Close: Jun 25, 2026
Exact Sciences Soars As Abbott Unveils $21 Billion Buyout
10:21am, Thursday, 20'th Nov 2025
Exact Sciences (EXAS) kept rallying on Thursday, climbing another ~18% in premarket trading after Abbott (ABT) officially confirmed it will acquire the cancer-t
Abbott's $21 Billion Exact Sciences Buyout Reshapes Cancer Diagnostics
09:37am, Thursday, 20'th Nov 2025
Abbott Laboratories (NYSE: ABT) agreed on Thursday to acquire cancer screening company Exact Sciences Corp (NASDAQ: EXAS) for $105 per common share, representing a total equity value of approximately
Why Abbott is paying $21 billion for Exact Sciences and its Cologuard cancer test
08:43am, Thursday, 20'th Nov 2025
Abbott is getting into the cancer-testing game with its $21 billion acquisition of Cologuard test maker Exact Sciences.
Exact Sciences Stock Soars. Abbott Is Buying It in Deal Valued at $21 Billion.
07:46am, Thursday, 20'th Nov 2025
Abbott Laboratories agrees to buy the cancer screening company in a cash deal.
Abbott to Acquire Exact Sciences for $21 Billion
07:46am, Thursday, 20'th Nov 2025
Abbott agreed to acquire Exact Sciences for $105 a share, representing a total equity value of about $21 billion.
Abbott bolsters diagnostics portfolio with up to $23 billion buyout of Exact Sciences
07:36am, Thursday, 20'th Nov 2025
Abbott said on Thursday it would buy cancer test maker Exact Sciences in an up to $23 billion deal, bolstering the medical device maker's diagnostics business.
Abbott to acquire Exact Sciences, a leader in large and fast-growing cancer screening and precision oncology diagnostics segments
07:30am, Thursday, 20'th Nov 2025
Acquisition adds a new growth vertical to Abbott's already high single-digit growth profile, gaining leadership in the fast-growing $60 billion U.S. cancer screening and precision oncology diagnostics
Exact Sciences Stock Jumps on Reported Deal Interest From Abbott Laboratories
04:27pm, Wednesday, 19'th Nov 2025
A report said the conglomerate Abbott Laboratories is close to a deal to acquire the company.
Abbott is weighing takeover of Exact Sciences, Bloomberg News reports
01:50pm, Wednesday, 19'th Nov 2025
Medical device maker Abbott Laboratories is nearing a potential takeover of cancer test maker Exact Sciences Corp , Bloomberg News reported on Wednesday, citing people familiar with the matter.
Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It
10:01am, Wednesday, 19'th Nov 2025
Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.
Abbott Laboratories $ABT Holdings Lowered by America First Investment Advisors LLC
03:08am, Wednesday, 19'th Nov 2025
America First Investment Advisors LLC decreased its position in shares of Abbott Laboratories (NYSE: ABT) by 1.2% during the undefined quarter, according to the company in its most recent disclosure w
Alberta Investment Management Corp Decreases Stake in Abbott Laboratories $ABT
03:31am, Monday, 17'th Nov 2025
Alberta Investment Management Corp cut its position in Abbott Laboratories (NYSE: ABT) by 81.7% during the second quarter, according to the company in its most recent 13F filing with the Securities an
Avantax Advisory Services Inc. Purchases 1,867 Shares of Abbott Laboratories $ABT
04:40am, Sunday, 16'th Nov 2025
Avantax Advisory Services Inc. increased its position in shares of Abbott Laboratories (NYSE: ABT) by 1.0% in the second quarter, according to its most recent disclosure with the Securities and Exchan
2 Sweet Dividend Stocks to Buy to Satisfy Your Craving for Passive Income
06:15pm, Saturday, 15'th Nov 2025
These companies are leaders in their industries and well-positioned to deliver steady growth over time. They also offer dividend yields higher than that of the S&P 500.
Why Is Abbott (ABT) Up 1.3% Since Last Earnings Report?
12:31pm, Friday, 14'th Nov 2025
Abbott (ABT) reported earnings 30 days ago. What's next for the stock?
